Diabetes Meds Flashcards
1st line tx for DM II
Metformin
Metformin mechanism
decrease Liver production of glucose (no effect on beta cells)
Added benefits:
- weight loss
- decrease triglycerides
- dec CVD risk
SE of GI complaints, metallic taste, Vit B12 def, Lactic acidosis
Metformin
Sulfa meds
“Gl____”
2nd gen (used more often)
- Glyburide
- Glipizide
- Glimepiride
1st gen
- Tolbutamide
- Chlorpropamide
Mechanism of sulfa
Stimulate beta cell Insulin release
similar glycemic efficacy as Metformin
SE of Sulfa
HYPOGLYCEMIA risk
Weight gain
Chlorpropamide (a 1st gen Sulfa med) has unique SE
Hyponatremia (low sodium)
Disulfuram like rxn (do not drink alcohol)
Meglitinides
“___glinide”
Repaglinide
Nateglinide
Repaglinide
Nateglinide
mechanism
Stimulate beta cell Insulin release
more so post prandial
SE of Metiglinides are same as sulfa
Hypoglycemia
Weight gain
Repaglinide is a good option for
pts with CKD
nice to the Kidneys
TZDs
Pioglitazone
Rosiglitazone
increase Insulin sensitivity at PERIPHERAL sites
SE of TZD
EDEMA
Fluid retention
BAD for CHF
Increased fractures
do NOT use TZD with
Type I DM HF Hx bladder CA High risk fractures Pregnancy
DPP-4 inhib
“gliptins”
Sitagliptin
Linagliptin
Saxagliptin
Sitagliptin
Linagliptin
Saxagliptin
are all
DPP-4
“gliptins”
Mechanism of “gliptins” (DPP-4 inhibitors)
Slow degradation of GLP-1 allowing that enzyme to do its job
leading to: increased Insulin sens, dec Glucagon secretion, decrease gastric emptying
SE of “gliptins” (DPP-4inibitors)
Acute Pancreatitis HA Hepatitis Skin change Joint pain Renal dysfx
Saxagliptin has a bad rep for being linked to
increased risk of HF (heart failure)
GLP-1 RA
Liraglutide
Exanatide
Dulaglutide
Lira
Exana
Dula
GLP-1 RA
Mechanism of GLP-1 RA
Mimics Incretin
- increase Insulin sensitivity
- decrease Glucagon release
- delay gastric emptying
Added benefits
- weight loss
- decrease CVD events
- no risk of Hypoglycemia if used alone
CONTRA to GLP-1RA
Lira
Exana
Dula
Hx of Gastroparesis
Hx of Pancreatitis
Hx of THYROID CA
Hx of MEN syndrome
SGLT-2 Inhibitors
“flozins”
Empagaflozin
Canagliflozin
Dapagiflozin
SGLT-2 Inhibitors
Proximal tubule
Increase glucose excretion
weak when used alone, thus often used in COMBO with: Pioglitazone, Sitagliptin, or Insulin
Benefit of SGLT-2 Inhibitors
Decrease CVD events
Lower BP
Weight loss
CONTRA to using SGLT “flozins”
Type I DM
or Type II DM if GFR <60 (need a good working kidney to use these)
Canagliflozin has a bad rep for being linked to
Amputation risk!!!
Caution in using SGLT2 inh “flozins” with other meds that can cause Dehydration
NSAIDs
ACE-I
ARBs
Diuretics
SE of SGLT 2 Inhib “flozins”
N/v Thirst AKI (acute kidney injury) Bone fracture UTI Yeast infection
Acarbose
Miglitol
Alpha glucosidase inhibitors
delay intestinal glucose absorption
less potent than Metformin and Sulfa
a-glucosidase inhibitors
- Acarbose
- Miglitol
SE
GI, flatulence, diarrhea, Hepatitis
safe in pts with Kidney issues
Two best meds for MACE prevention
Empagaflozin (SGLT)
Liraglutide (GLP)
Lispro
Aspart
Rapid acting insulin
Lispro, AKA
HUmalog
Aspart, AKA
Novolog